Real world biologic treatment response in severe asthma:: an analysis of the International Severe Asthma Registry (ISAR)
Le, T. T., Scelo, G., Tran, T. N., Faregas, M., Martin, N., Menzies-Gow, A. N., Eileen, W., Wechsler, M. E., Walter Canonica, G., Heffler, E., Heaney, L. G., Jackson, D., Pfeffer, P., Busby, J., Porsbjerg, C. M., Hew, M., Peters, M., Gibson, P. G., Al-Ahmad, M., Bergeron, C., Sadatsafavi, M., Llano, L. P. d., Cosio, B. G., Kuna, P., Perng, D., Iwanaga, T., Torres-Duque, C. A., Linnemann, D. L., Mahboub, B., Papadopoulos, N. G., Al-Lehebi, R., Fonseca, J. A., Rhee, C. K., Maspero, J., Siyue, M. K., Christoff, G. C., Popov, T. A., Kwiatek, J., Carter, V., Goh, C., Bulathsinhala, L., Beastall, A., Price, D.
ERS 2023 International Congress
Contributions to Conferences: Abstracts
Real-world associations between outcomes and biomarkers in severe asthma patients treated with biologics
Townend, J., N TRAN, T., Martin, N., Menzies-Gow, A. N., Wang, E., Wechsler, M. E., Walter Canonica, G., Heffler, E., Llano, L. P. d., Cosio, B. G., Hew, M., Peters, M., Gibson, P. G., Bosnic-Anticevitch, S., Heaney, L. G., Jackson, D. J., Pfeffer, P. E., Busby, J., Salvi, S., Christoff, G. C., Popov, T. A., Porsbjerg, C. M., Torres-Duque, C. A., Al-Lehebi, R., Al-Ahmad, M., Perng, D. W., Bergeron, C., Sadatsafavi, M., Mahboub, B., Iwanaga, T., Maspero, J. F., Kuna, P., Rhee, C. K., Larenas-Linnemann, D., Papadopoulos, N. G., Papaioannou, A. L., Fonseca, J. A., Koh, M. S., Costello, R. W., Price, D.
Contributions to Conferences: Abstracts
Biomarkers expression, treatment and disease burden in a cohort of Italian patients affected by severe asthma: a sub analysis of the ISAR EVEREST study
Heffler, E., Canonica, G. W., Blasi, F., Paggiaro, P., Brussino, L., Caminati, M., Bagnasco, D., Camiciottoli, G., Bonini, M., Pelaia, G., Detoraki, A., Crimi, C., Boarino, S., Cristofari, G., Erhard, C., Carter, V., Price, D., Cook, B., Tram, T. N., Le, T. T., SANI and ISAR EVEREST study groups
EAACI Congress 2023, pp. TP-A25
Contributions to Conferences: Abstracts
Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study
Bonini, M., Canonica, G. W., Blasi, F., Paggiaro, P., Heffler, E., Brussino, L., Caminati, M., Bagnasco, D., Camiciottoli, G., Pelaia, G., Detoraki, A., Crimi, C., Boarino, S., Cristofari, G., Erhard, C., Carter, V., Price, D., Cook, B., Tran, T. N., Le, T. T., SANI and ISAR EVEREST study groups
EAACI Congress 2023
Contributions to Conferences: Abstracts
Identification of key opportunities for optimising the management of high-risk COPD patients in the UK using the CONQUEST Quality Standards: an observational longitudinal study
Halpin, D. M., Dickens, A. P., Skinner, D., Murray, R. B., Singh, M., Hickman, K., Carter, V., Couper, A., Evans, A., Pullen, R., Menon, S., Morris, T., Muellerova, H., Bafadhel, M., Chalmers, J., Devereux, G., Gibson, M., Hurst, J. R., Jones, R., Kostikas, K., Quint, J., Singh, D., van Melle, M., Wilkinson, T. M., Price, D.
The Lancet Regional Health - Europe, vol. 29, 100619
Questions in Mild Asthma: An Official American Thoracic Society Research Statement
Mohan, A., Lugogo, N. L., Hanania, N. A., Reddel, H. K., Akuthota, P., O'Byrne, P. M., Guilbert, T., Papi, A., Price, D., Jenkins, C. R., Kraft, M., Bacharier, L. B., Boulet, L., Yawn, B. P., Pleasants, R., Lazarus, S. C., Beasley, R., Gauvreau, G., Israel, E., Schneider-Futschik, E. K., Yorgancioglu, A., Martinez, F., Moore, W., Sumino, K.
American journal of respiratory and critical care medicine, vol. 207, no. 11, pp. e77-e96
Association Between T2-related Comorbidities and Effectiveness of Biologics in Adult Patients From the International Severe Asthma Registry
Price, D., Scelo, G., Porsbjerg, C., Murray, R., Tran, T. N., Martin, N., Al-Ahmad, M., Al-Lehebi, R. O., Bergeron, C., Busby, J., Canonica, G., Christoff, G., Rhee, C., Cosio, B. G., Fonseca, J., Heaney, L., Heffler, E., Popov, T., Sadatsafavi, M., Salvi, S., Torres-Duque, C. A., Wang, E., Wechsler, M. E., Hew, M., Iwanaga, T., Jackson, D. J., Kuna, P., Larenas-Linnemann, D., Mahboub, B., Máspero, J., Menzies-Gow, A., Papadopoulos, N., Perng, D., Peters, M., Pfeffer, P., PRISM working group
The influence of mixing inhaler devices on inhaler technique in COPD
Kerkhof, M., Driessen, M., Gerritsma, Y., Bosnic-Anticevich, S., Correia de Sousa, J., Dekhuijzen, R., Kerstjens, H. A., Leving, M., Price, D., Tsiligianni, I., Usmani, O.
Diagnostic Performance of a Machine Learning Algorithm (Asthma/Chronic Obstructive Pulmonary Disease [COPD] Differentiation Classification) Tool Versus Primary Care Physicians and Pulmonologists in Asthma, COPD, and Asthma/COPD Overlap
Kocks, J. W., Cao, H., Holzhauer, B., Kaplan, A., FitzGerald, J. M., Kostikas, K., Price, D., Reddel, H. K., Tsiligianni, I., Vogelmeier, C. F., Bostel, S., Mastoridis, P.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 5, pp. 1463-1474
Chronic Airways Assessment Test: Psychometric properties in patients with asthma and/or COPD
Tomaszewski, E. L., Atkinson, M. J., Janson, C., Karlsson, N., Make, B., Price, D., Reddel, H. K., NOVELTY study investigators, NOVELTY Scientific Community
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: study protocol for a cluster randomised controlled implementation trial
McClatchey, K., Hammersley, V., Steed, L., Sheringham, J., Marsh, V., Barat, A., Delaney, B., Hamborg, T., Fitzsimmons, D. F., Holmes, S., Jackson, T., Ehrlic, E., Morgan, N., Saxon, A., Preston, M., Price, D., Taylor, S. J., Pinnock, H., IMP2ART Programme Group.
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
pfeffer, p., Ali, N., Murray, R., Ulrik, C., Tran, T., Maspero, J., Peters, M., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Altraja, A., Lehtimäki, L., Papadopoulos, N., Salvi, S., Costello, R. W., Cushen, B., Heffler, E., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., Kuna, P., Fonseca, J., Al-Lehebi, R., Rhee, C. K., Llano, L. P. d., Perng, D., Mahboub, B., Wang, E., Goh, Y. Y. C., Lyu, J., Newell, A., Alacqua, M., Bhutani, M., Bjermer, L., Björnsdóttir, U. S., Bourdin, A., Bülow, A. V., Busby, J., Canonica, W., Cosio, B. G., Dorscheid, D., Esquerre, M. M., FitzGerald, M., Gil, E. G., Gibson, P. G., Heaney, L., Hew, M., Hilberg, O., Hoyte, F., Jackson, D., Koh, M., Ko, H., Lee, J. H., Lehmann, S., Loureiro, C. C., Ludviksdottir, D., Menzies-Gow, A., Mitchell, P., Papaioannou, A., Popov, T., Porsbjerg, C., Salameh, L., Sirena, C., Taillé, C., Taube, C., Tohda, Y., Wechsler, M. E., Price, D.
Application of an algorithm to analyze patterns of intermittent oral corticosteroid use in asthma
Haughney, J., Tran, T. N., Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Chan, J. S. K., Price, D.
npj Primary Care Respiratory Medicine, vol. 33, no. 1, 9
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S. Z., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D., Beekman, M., Stewart, D.
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
Lyu, J., Rhee, C. K., Tran, T. N., Katial, R., Martin, N., Peters, M., Denton, E., Upham, J. W., Bardin, P. G., Cochrane,, B., Middleton, P. G., Reynolds, P. M., Perng, D. W., Wang, H., Sheu, C., Tsai, M., Wan-Chun Huang, E., Chien, Y., Hsu, J., Fu, P., Lin, C., Lin, S., Shen, S., Liu, S., Lee, K., Chiu, K., Lin, H., Lin, M., Chou, C., Salvi, S., Cho, Y. S., Yoo, K. H., Iwanaga, T., Tohda, Y., Fujimoto, H., Tanaka, H., Nogami, K., Sekiya, K., Matsunaga, M., Soichiro, H., Fujisawa, T., Nagano, T., Kobayashi, T., Oguma, T., Nishimura, Y., Murray, R. B., Bulathsinhala, L., Joshi, I., Eleangovan, N., Skinner, D., Carter, V., Price, C., Price, D.
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
Park, H. Y., Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D.
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
Price, D., Jenkins, C., Hancock, K., Hancock, K., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Bateman, E. D.
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
Pavord, I. D., Tran, T. N., Jones, R., Nuevo, J., van den Berge, M., Brusselle, G., Menzies-Gow, A., Skinner, D., Carter, V., Kocks, J. W. H., Price, D.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543
